UPDATE: Bank of America Reiterates on Genomic Health as 2014 Outlook is …

In the report, Bank of America noted, “GHDX expects to deliver 15-20% test vol. growth in FY14 , assuming single-digit growth in the core US invasive breast cancer mkt, further penetration into int'l mkts, particularly W. Europe, greater traction from




http://ift.tt/eA8V8J

0 comments:

Post a Comment